
AngioDynamics ANGO
$ 12.03
7.41%
Quarterly report 2026-Q1
added 04-02-2026
AngioDynamics Total Inventories 2011-2026 | ANGO
Annual Total Inventories AngioDynamics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 M | 60.6 M | 55.3 M | 51.4 M | 48.6 M | 59.9 M | 40.1 M | 48.9 M | 54.5 M | 55.4 M | 67.4 M | 61.2 M | 55.1 M | 55.8 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 67.4 M | 40.1 M | 55.4 M |
Quarterly Total Inventories AngioDynamics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.6 M | 62.3 M | 62 M | 63.1 M | 65.9 M | 64.7 M | 60.6 M | 58.1 M | 64.3 M | 60 M | 55.3 M | 63.5 M | 63.2 M | 57.6 M | 51.4 M | 48 M | 48.2 M | 49.3 M | 48.6 M | 48.6 M | 49.6 M | 52.8 M | 59.9 M | 59.9 M | 50.2 M | 45.2 M | 40.1 M | 40.1 M | 50.6 M | 49.7 M | 39.3 M | 48.9 M | 54 M | 55.4 M | 54.5 M | 54.5 M | 56.7 M | 58.3 M | 55.4 M | 55.4 M | 70.8 M | 74.3 M | 67.4 M | 67.4 M | 75.4 M | 71.3 M | 75.3 M | 70.4 M | 60.1 M | 59.2 M | 55.1 M | 55.1 M | 62.3 M | 63.4 M | 55.8 M | 55.8 M | 29.4 M | 29.7 M | 28.1 M | 28.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.4 M | 28.1 M | 55.6 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
846 M | $ 62.02 | 2.78 % | $ 12.3 B | ||
|
Glaukos Corporation
GKOS
|
63.6 M | $ 121.69 | 7.24 % | $ 6.96 B | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 418.82 | 2.83 % | $ 149 B | ||
|
ICU Medical
ICUI
|
616 M | $ 134.93 | 3.38 % | $ 3.32 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 4.14 | 5.61 % | $ 191 M | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 107.35 | 2.67 % | $ 3.44 B | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | - | - | $ 2.12 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 178.9 | 0.07 % | $ 9.54 B | ||
|
Microbot Medical
MBOT
|
584 K | - | - | $ 89.7 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.43 | 11.28 % | $ 35.3 M | ||
|
electroCore
ECOR
|
1.63 M | $ 9.94 | 0.81 % | $ 84.3 K | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 22.87 | 2.1 % | $ 3.84 B | ||
|
Haemonetics Corporation
HAE
|
306 M | $ 69.85 | 6.03 % | $ 3.3 B | ||
|
Isoray
ISR
|
1.41 M | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
632 M | $ 212.24 | 0.98 % | $ 20.8 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 29.86 | 5.66 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
5.39 M | $ 9.12 | 1.0 % | $ 188 M | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 132.11 | 2.76 % | $ 5.9 B | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 63.04 | 3.94 % | $ 3.73 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 67.99 | 3.75 % | $ 220 M | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 317.32 | 0.32 % | $ 22.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 9.88 | 2.49 % | $ 1.97 B | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 26.94 | 7.8 % | $ 1.82 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.66 | 0.41 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 67.0 | 2.81 % | $ 220 M | ||
|
Predictive Oncology
POAI
|
45.8 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
30.2 M | - | - | $ 1.29 B | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.88 | 2.17 % | $ 171 M | ||
|
Baxter International
BAX
|
2.23 B | $ 19.35 | 4.31 % | $ 9.93 B | ||
|
ResMed
RMD
|
744 M | $ 194.32 | 4.2 % | $ 28.4 B | ||
|
AtriCure
ATRC
|
78.5 M | - | - | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
20.8 M | - | - | $ 288 M | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 149.56 | 2.73 % | $ 43 B | ||
|
Nephros
NEPH
|
3.23 M | $ 3.59 | -1.37 % | $ 38.1 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 4.17 | 5.57 % | $ 306 M | ||
|
Repligen Corporation
RGEN
|
170 M | $ 126.55 | 3.96 % | $ 7.12 M |